Anamnesis Bio
Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.
About
Anamnesis Bio is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. They leverage a deep understanding of disease mechanisms to create targeted therapies with the potential to significantly impact patient outcomes. Their approach aims to address unmet needs in conditions like Alzheimer's and Parkinson's.
Technology stack
detected 2026-06-12Est. monthly stack spend~$70/mo
Email
Google Workspace
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Anamnesis Bio do?
Anamnesis Bio is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. They leverage a deep understanding of disease mechanisms to create targeted therapies with the potential to significantly impact patient outcomes. Their approach aims to address unmet needs in conditions like Alzheimer's and Parkinson's.
Where is Anamnesis Bio headquartered?
Anamnesis Bio is headquartered in תל אביב - יפו, Israel.
When was Anamnesis Bio founded?
Anamnesis Bio was founded in 2023.
What industry does Anamnesis Bio operate in?
Anamnesis Bio operates in Biotech, HealthTech, Drug Discovery, Neurotech, Longevity, Genomics.